Quinprenaline

Quinprenaline
Clinical data
Other names	Quinterenol
Drug class	β-Adrenergic receptor agonist; Sympathomimetic; Bronchodilator
Identifiers
	IUPAC name 5-[1-hydroxy-2-(propan-2-ylamino)ethyl]quinolin-8-ol;
CAS Number	13757-97-6;
PubChem CID	26258;
ChemSpider	24465;
UNII	100EPZ8Y7G;
ChEMBL	ChEMBL2009119;
CompTox Dashboard (EPA)	DTXSID70864439 ;
Chemical and physical data
Formula	C14H18N2O2
Molar mass	246.310 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC(C)NCC(C1=C2C=CC=NC2=C(C=C1)O)O;
	InChI InChI=1S/C14H18N2O2/c1-9(2)16-8-13(18)10-5-6-12(17)14-11(10)4-3-7-15-14/h3-7,9,13,16-18H,8H2,1-2H3; Key:RSDQHEMTUCMUPQ-UHFFFAOYSA-N;

Quinprenaline (INNTooltip International Nonproprietary Name; also known as quinterenol) is a sympathomimetic, long-acting β-adrenergic receptor agonist, and bronchodilator of the phenethylamine family that was never approved for human use.^[1]^[2]^[3]^[4]^[5] It was first described by the 1960s.^[2]^[4]

References

↑ Elks J (2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer US. p. 1060. ISBN 978-1-4757-2085-3. Retrieved 27 February 2025.
1 2 Larsen AA, Dungan KW (January 1968). "Pulmonary and Antiallergy Agents.". Annual Reports in Medicinal Chemistry. Vol. 3. Academic Press. pp. 84–92 (87). doi:10.1016/s0065-7743(08)61313-5. ISBN 978-0-12-040503-9.
↑ Broadley KJ (2017). Autonomic Pharmacology. CRC Press. p. 193. ISBN 978-1-135-74138-9. Retrieved 27 February 2025.
1 2 Aviado DM, Bowman WC, Burnstock G, Greven J, Hannappel J, Juul P, et al. (2012). Adrenergic Activators and Inhibitors: Part II. Handbook of Experimental Pharmacology. Springer Berlin Heidelberg. p. 81. ISBN 978-3-642-67584-3. Retrieved 27 February 2025.
↑ Milne GW (2018). Drugs: Synonyms and Properties. Routledge Revivals. Taylor & Francis. p. 518. ISBN 978-1-351-78990-5. Retrieved 27 February 2025.

This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by adding missing information.